ISLR and colorectal carcinoma: Taken together, our in vitro studies indicate that modulating stromal, secreted BMP regulators of BMP signaling through either GREM1-neutralizing antibody or Islr-overexpression facilitates Lgr5+ intestinal stem cell differentiation and diminishes CRC tumoroid growth.